Amundi
AGL icon

Amundi’s Agilon Health AGL Stock Holding History

Amundi’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.6M Buy
+70,954
New +$4.65M ﹤0.01% 948
2026
Q1 		– Sell
-78,772
Closed -$1.36M – 2035
2025
Q4 		$1.36M Buy
+78,772
New +$1.53M ﹤0.01% 1216
2025
Q3 		– Sell
-71,824
Closed -$4.29M – 1590
2025
Q2 		$4.29M Buy
71,824
+12,436
+21% +$997K ﹤0.01% 951
2025
Q1 		$5.94M Buy
59,388
+19,576
+49% +$1.7M ﹤0.01% 926
2024
Q4 		$2.18M Buy
39,812
+1,139
+3% +$68.9K ﹤0.01% 1171
2024
Q3 		$3.05M Buy
38,673
+38,639
+113,644% +$4.99M ﹤0.01% 1076
2024
Q2 		$5.1K Sell
34
-29,472
-100% -$4.2M ﹤0.01% 1887
2024
Q1 		$3.97M Sell
29,506
-16,730
-36% -$2.78M ﹤0.01% 1009
2023
Q4 		$9.76M Buy
46,236
+5,116
+12% +$1.85M ﹤0.01% 848
2023
Q3 		$18.7M Buy
41,120
+15,343
+60% +$6.93M 0.01% 703
2023
Q2 		$10.9M Sell
25,777
-16,838
-40% -$9.46M 0.01% 830
2023
Q1 		$27.6M Buy
42,615
+2,060
+5% +$1.15M 0.01% 644
2022
Q4 		$19.4M Buy
40,555
+11,994
+42% +$5.62M 0.01% 703
2022
Q3 		$17.1M Sell
28,561
-13,675
-32% -$8.19M 0.01% 731
2022
Q2 		$27.4M Buy
42,236
+12,869
+44% +$6.51M 0.02% 559
2022
Q1 		$18.2M Buy
29,367
+3,748
+15% +$1.93M 0.01% 694
2021
Q4 		$13.2M Buy
25,619
+24,192
+1,695% +$14.7M 0.01% 777
2021
Q3 		$935K Buy
+1,427
New +$1.22M ﹤0.01% 1304

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Amundi's AGL Position: Q2 2026 in Review

Amundi opened a new position in Agilon Health (AGL) in Q2 2026: 70,954 shares worth $7.6M. The stake represents ﹤0.01% of the portfolio and ranks #948 among its holdings. This is a return to the name: Amundi previously reported a position in AGL as recently as Q4 2025.

Amundi first reported a position in AGL in Q3 2021 and has held it in 18 quarters since. The position peaked at $27.6M in Q1 2023. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Amundi held 70,954 shares of Agilon Health worth $7.6M as of Q2 2026.
  • Agilon Health was a new Amundi position in Q2 2026.
  • Agilon Health made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #948 holding.
  • Amundi first reported a position in Agilon Health in Q3 2021 and has held it in 18 quarters since.
  • Amundi's Agilon Health position peaked at $27.6M in Q1 2023.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.